CSSi News

Global Patient Recruitment Company CSSi Launches Redesigned Website

May 10, 2017

SmartStudy EMR

The new website offers improved functionality and increased benefits to visitors

CSSi, the global leader in patient recruitment, enrollment and retention solutions for the clinical research industry, is proud to announce the launch of its newly redesigned website, www.CSSiEnroll.com. The new website features both enriched content and a customized layout that provides a better overall user experience and enhances the company's already well-established position as the top global patient recruitment company in the industry.

“After many months of hard work, we are delighted to officially announce the relaunch of our new and improved company website,” said Chris Trizna, President, CSSi. “We hope our redesigned website exceeds our current and prospective clients’ expectations; we really worked hard to make sure it contains valuable patient recruitment information, solutions and services to assist them with meeting their enrollment goals. With the changes and upgrades, we expect maximized audience engagement and tremendous leads through our new convenient, user-friendly website.”

The goal of CSSi’s website redevelopment effort was focused on aesthetics, simplifying content and increasing the visibility of the company’s brand. The new website is both visually appealing and user-friendly which provides visitors with streamlined menus, clear navigation and better access to useful information about the company’s outstanding services and recent successes.

Newly revamped pages of www.CSSiEnroll.com include:

  • Capabilities – Navigate through a library of tools and service offerings, customizable to each study, that CSSi utilizes to ensure the most efficient and cost-effective method to reaching a client’s enrollment goals.
  • Therapeutic Areas & Case Studies – Highlights CSSi’s vast patient recruitment experience, with the completion of over 1,200 studies in the last three years within 17 therapeutic areas and 120 unique indications.
  • CSSi Creative Profile – Showcases the company’s broad scope of work and various creatives that have been used to successfully recruit patients. Users can get an in-depth look into CSSi’s creative development process, which involves a thorough analysis of the industry, health indication and a client’s needs and challenges. CSSi strives to develop a unique, powerful study brand and the enrollment tools that each investigative site needs to effectively enroll study subjects.

The website relaunch comes on the heels of CSSi’s 12-year anniversary. “I am so incredibly proud of my team and all that we have accomplished over the years and to be a part of an industry that brings new drugs and devices to market to help people with chronic illnesses all across the globe. Our quality of work has been top notch and crucial to our continued patient recruitment success. We look forward to many more years of growth for CSSi and the industry!” added Trizna.

About CSSi:

CSSi delivers global patient recruitment solutions to study sponsors, CROs, SMOs and investigative sites that ensure successful enrollment on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSSi is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. For more information on CSSi, please email: info@CSSiEnroll.com or call: (866) 277-4888.

Follow Us!
Facebook.com/CSSiEnrollTwitter.com/EnrollPatientsLinkedIn.com/Company/Clinical-Site-Services

CSSi Lifesciences™ Partners with AccenGen to Develop New Class of Anti-inflammatory Drugs

Post date: December 8, 2015

New anti-inflammatory drug

Glen Burnie, MD - CSSi LifeSciences™ (www.CSSiLifeSciences.com) has formalized an agreement with AccenGen, a San Francisco based early-stage pharmaceutical company to develop novel drugs that hold great promise in the treatment of a range of inflammation-related conditions.

AccenGen selected CSSi LifeSciences™ because of its best in class services to efficiently develop AccenGen’s soluble epoxide hydrolase (sEH) inhibitors and ensure the most efficient path to drug development. sEH inhibitors are a new class of anti-inflammatory drugs that target problems at the source, providing a safer, more effective mechanism of treatment for patients. sEH inhibitors have been indicated as a treatment for a range of diseases and conditions including scleroderma, fibrosis, asthma, atrial fibrillation, arrhythmias, sinusitis, allergies and pain.

“We are excited to establish our strategic partnership with AccenGen to leverage our strategic commercial drug development services to develop a novel new class of drugs. The sEH inhibitors have the potential to address a large unmet need,” said Jim Sergi, President of CSSI LifeSciences™.

About CSSi LifeSciences™

CSSi LifeSciences™ provides fully integrated, specialized regulatory and clinical services to support the entire product lifecycle, from discovery to commercialization, for pharmaceutical and medical device companies. As a trusted partner, CSSi LifeSciences™ provides a comprehensive suite of scalable services with cost efficient predictability, which drives product value, extends market share, and maximizes ROI. With global expertise, CSSi LifeSciences™ has been a key partner in the development of more than 500 drugs, biologics, medical devices and in-vitro diagnostics. Visit www.CSSiLifeSciences.com or contact Jim Sergi at jsergi@cssienroll.com

About AccenGen

AccenGen Therapeutics, Inc. is an early stage pharmaceutical company focused on developing products using soluble epoxide hydrolase (sEH) inhibitors and (sEHI) for indications with inflammatory etiologies, highest unmet needs and largest markets. For more information, visit www.accengen.com, call (844) 422-2364, or email: info@AccenGen.com

CSSi LifeSciences™ and PRC Clinical Join Forces to Offer Extended Clinical Trial Services

Post date: July 29, 2015

CSSi Team Work

Glen Burnie, MD - CSSi LifeSciences™ (www.CSSiLifeSciences.com) formalized a strategic partnership agreement with PRC Clinical, a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences™ is specialized in strategic, marketing, and regulatory consulting, FDA advisory services, and patient recruitment services. The core expertise of PRC Clinical is focused on Clinical Trial Management, Clinical Site Monitoring, and Clinical Payment Services. The CSSi LifeSciences™ and PRC Clinical partnership equips both firms with the ability to guide and support sponsors through the entire drug development lifecycle, from strategic, regulatory, clinical operations, and marketing standpoints.

CSSi LifeSciences™ has successfully supported the development of over 500 new drugs, biologics, medical devices and in-vitro diagnostics for sponsors in the United States, Europe, Asia, and the Middle East. PRC Clinical has supported phase I-IV clinical studies for pharmaceutical and medical device companies globally. CSSi LifeSciences™ and PRC Clinical are respectively headquartered in Baltimore, MD and San Bruno, CA. The signature of this partnership agreement will strengthen both firms in their ability to seamlessly support sponsors across the United States and Globally.

“We are excited to establish our strategic partnership with PRC Clinical to leverage our skills, services and brain trust to help bring complementary and specialized clinical trial services to local and global clients,” said Jim Sergi, President of CSSI LifeSciences™. The new partnership benefits pharmaceutical and medical device companies by simplifying the outsourcing process for full-service projects.

“The PRC Clinical team is excited to work in a formalized relationship with CSSi LifeSciences™ and to support local and global clinical trials across the drug development lifecycle,” stated Curtis Head, CEO at PRC Clinical.

CSSi LifeSciences™ and PRC Clinical share a strong belief in providing personalized client and patient centric services, as well as a similar management style in providing uncompromising SOP driven standards. In joining resources, clients will receive best in class services to provide insight driven analysis and more informed decision making to increase commercial success, while reducing the risk for late-stage failures and post-authorization action.

About CSSi LifeSciences™

CSSi LifeSciences™ provides fully integrated, specialized regulatory and clinical services to support the entire product lifecycle, from discovery to commercialization, for pharmaceutical and medical device companies. As a trusted partner, CSSi LifeSciences™ provides a comprehensive suite of scalable services with cost efficient predictability, which drives product value, extends market share, and maximizes ROI. With global expertise, CSSi LifeSciences™ has been a key partner in the development of more than 500 drugs, biologics, medical devices and in-vitro diagnostics. Visit www.CSSiLifeSciences.com or contact Jim Sergi at jsergi@cssienroll.com

About PRC Clinical

PRC Clinical is a Silicon Valley-based CRO specializing in Clinical Trial Management, supporting phase I-IV clinical studies for pharmaceutical and medical device companies globally in 19 countries. Founded in 2003, PRC Clinical offers Clinical Trial Management services including Site Monitoring, Quality Assurance, Drug Safety, Clinical Project Management, Payment Services, Biostatistics, Data Management, and CTMS. PRC clinical has significant CRO experience in conducting phase I-IV clinical studies in a wide range of Therapeutic areas & Case Studies: CNS, Neurology, Pain, GI, Device, Anti-infective, Cardiovascular, Pulmonary, Oncology, Endocrine, ALS, Parkinson’s, and Stem cells. Visit http://www.prcclinical.com, call 1-877-519-6001, or email info@prcclinical.com .

CSSi in the Community

December 2016

CSSi SPAN

CSSi assumed the role of Santa's helpers for the SPAN, Inc. 2016 Holiday Caring Program, where our staff shopped for, wrapped and placed Christmas gifts under the Christmas tree for the taking. Our contributions will go to a select few of the many local area families and children that SPAN is providing gifts to this year. Through our efforts, we hope we can spread some holiday cheer and help create new holiday memories for our neighbors in need!

November 2016

CSSi SPAN

CSSi staff, family, and friends showed their continued support for SPAN, Inc., it's mission, and local Anne Arundel County area families in crisis by participating in the 2016 Stride for SPAN 5K Race/1 Mile Fun Walk. The event was a great success and very rewarding for all of our participants! We are already looking forward to next year's event!

November 2016

CSSi ALZ Walk

November is National Alzheimer's Disease Awareness & Caregivers Month! CSSi is committed to supporting Alzheimer’s research through community events, our in-office expert, existing networks, and the success of our services. We took the first step to a world without Alzheimer's by participating in not just one, but two, Walk to End Alzheimer’s in the Greater Baltimore and Anne Arundel County areas. Get involved now and help raise awareness in your community! Join the movement to ending Alzheimer's disease by visiting the Alzheimer's Association's website - www.alz.org.

September 2016

CSSi VEDA

CSSi decided to join in on the fun and wanted show our support for Vestibular Disorders Association (VEDA) by participating in its "Flat Flamingo Photo Contest". This photo challenge is meant to help raise awareness about vesitbular disorders. We challenge you to flaunt your Flat Flamingo and help VEDA #defeatdizziness! Learn more about VEDA and how to get involved or donate: vestibular.org.#BalanceAwarenessWeek

August 2016

CSSi MD Food Bank

CSSi had two groups of eager volunteers pitch in at the Maryland Food Bank to help support the movement to end hunger in MD. The teams sorted and packed food delivered to its warehouse as well as helped bag and flash-freeze meals from its kitchen, all to be distributed to its network of partners. It was a very rewarding experience, and we look forward to continuing our long-standing commitment to volunteerism at our next community outing! Learn more about the Maryland Food Bank's hunger relief efforts and available volunteer opportunities here: http://bit.ly/2bYlxWA.

June 2016

CSSi Alzheimer's Awareness month

Our staff dressed down for the day and wore purple in support of Alzheimer's & Brain Awareness Month! We wanted to join in on the movement of helping shine a purple light for the millions of individuals around the world and all of the people in our community who are affected by Alzheimer's. We challenge you to do the same! #ENDALZ

April 2016

CSSi Serverna Park High School Run

This past Saturday, the CSSi team took part in the Run 4 Rhythm Fun Run/Walk at Severna Park High School (SPHS). With help from some formal training and the beautiful weather, CSSi participants were able to the complete the four-mile-long course, along the B&T Trail, with ease. Proceeds from this exciting event benefited the SPHS Band & Orchestra Boosters. Congratulations to all participants and on a successful event!

CSSi LifeSciences™ Hosting During the J.P. Morgan 34th Annual Healthcare Conference

Post date: December 9, 2015

CSSi J.P. Morgan

CSSi LifeSciences™ along with their strategic partners, PRC Clinical and Statistics & Data Corporation will have a Hospitality Suite during the upcoming J.P. Morgan Annual Healthcare Conference, to be held in San Francisco, January 11 – January 14, 2016.

The annual event provides an opportunity for life science, biotech and health companies to meet with potential investors with billions of dollars under management, pensions, foundations and endowments.

Located at the Hilton San Francisco Union Square, CSSi LifeSciences™ and their strategic partners will be hosting in the Golden Gate 1 meeting room for each of the four days beginning at 8 am. A featured guest speaker will be presenting each day on specific topics of interest. The presentation schedule will be posted at a later date at www.CSSiLifesciences.com

About CSSi LifeSciences™

CSSi LifeSciences™ provides fully integrated, specialized regulatory and clinical services to support the entire product lifecycle, from discovery to commercialization, for pharmaceutical and medical device companies. With global expertise, CSSi LifeSciences™ has been a key partner in the development of more than 500 drugs, biologics, medical devices and in-vitro diagnostics.

About PRC Clinical

PRC Clinical is a Silicon Valley-based CRO specializing in Clinical Trial Management, supporting phase I-IV clinical studies for pharmaceutical and medical device companies globally in 19 countries. Visit www.prcclinical.com.

About Statistics & Data Corporation

Statistics & Data Corporation (SDC), based in Tempe, Arizona, is a specialized data services Contract Research Organization (CRO) providing scalable full-service solutions since 2005. For more information, visit www.sdcclinical.com.

CSSi Exhibiting at the 52nd Drug Information Association Annual Meeting in Philadelphia, PA

June 1, 2016

CSSi MD Food Bank

Glen Burnie, MD – CSSi, the global leader in patient recruitment, enrollment and retention solutions for the clinical research industry, today announced that the company will be exhibiting in booth 1000 at this year’s 52nd Drug Information Association (DIA) Annual Meeting. The five-day event is scheduled to take place from Sunday, June 26 – Thursday, June 30, 2016 at the Philadelphia Convention Center in Philadelphia, PA.

DIA 2016 is the largest global interdisciplinary drug industry event bringing together an extensive network of life science professionals at all levels and across all disciplines to encourage innovation and support the development of safe and effective medical products and therapies to patients. With over 7,000 conference attendees expected, CSSi will have the rare opportunity to increase its knowledge of the development of new therapies and quicken efforts to enhance health and well-being globally, as well as facilitate trusted relationships with the top industry leaders and established organizations that drive and share a similar mission and values. It will provide CSSi with an invaluable learning experience and a chance to showcase its global therapeutic experiences, patient engagement capabilities, and unique Local Enrollment Specialist services.

“CSSi is excited to participate in this year’s ‘can’t miss event’ as an exhibitor,” says Chris Trizna, President, CSSi. “At DIA 2016, we look forward to further expanding our industry reach and enabling more companies to not only meet, but also exceed, their patient recruitment and enrollment goals.”

DIA 2016 will provide an instrumental opportunity for global innovators involved in the discovery and commercialization of pharmaceuticals, medical devices, and related products, including discussion of current and evolving areas such as comparative effectiveness research, health outcomes, and drug/device combination products. The event will feature over 95 senior leaders from international regulatory authorities, more than 75 educational offerings over 22 tracks on today’s most relevant industry topics, and numerous panel discussions conducted by leaders from the International Coalition of Medicines Regulatory Authorities (ICMRA), among other organized activities.

CSSi is the only global patient recruitment organization that tailors its support and services around each individual site's needs to help it successfully reach patient recruitment goals. With decades of experience and thousands of trials supported globally and nationally, CSSi is a full-service company with an array of superb patient recruitment, enrollment, and retention solutions.

About CSSi:

CSSi delivers global patient recruitment solutions that ensure successful enrollment, on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSSi is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. For more information on CSSi, visit www.CSSiEnroll.com, or email at info@cssienroll.com.

Introducing

November 2, 2016

SmartStudy EMR

CSSi's SmartStudy™ EMR is unique in that it can be used during site feasibility and patient recruitment, from a secure and compliant virtual, cloud based system.

SmartStudy™ EMR Features & BenefitsInclude:

Site Feasibility - Accurately identifies the most productive sites by providing a snapshot of the site’s true patient population for eligibility. Site selection is based on EMR patient-centric data.

Patient Recruitment - Rapidly and efficiently identifies the most eligible patients by providing sites an automated protocol query against their database, presenting only those patients who meet the protocol’s entry criteria. When paired with our Local Enrollment Specialist™ solution, this platform makes it easy for busy sites to accurately identify and recruit eligible patients.

CSSi LifeSciences™ Launches Fully Integrated Medical Device CRO

November 2, 2016


Accelerating Research Breakthroughs and Product Developments to Commercialization

Glen Burnie, Md. (November 2, 2016) – CSSi LifeSciences™, a trusted partner from discovery to commercialization for drugs and medical devices, is excited to announce the establishment and launch of its fully integrated Medical Device CRO. CSSi LifeSciences™ Medical Device CRO aims to positively impact the timeline of regulatory clearance and increase profitability for medical device companies, in order to successfully launch their innovative research discoveries and product concepts into the market.

CSSi LifeSciences™ supports small and large companies in avoiding the “large CRO shuffle” by providing highly specialized regulatory and clinical expertise in medical devices, while also offering unparalleled and cost-efficient services from start to finish. The company’s goal is to accelerate product development by providing insight-driven guidance that saves time and cost.

“The pathway to commercialization for a new medical device can be ambiguous and complex due to ever-changing regulations and requirements. To help companies overcome this barrier, we developed our unique Medical Device CRO,” said Jim Sergi, President and Partner, CSSi LifeSciences™. “We take pride in being an industry leader, as well as creating a new breed of CRO, one that focuses specifically on the medical device industry. We believe taking this approach in today’s new world of healthcare is intelligent, critically honest, and backed by a history of verifiable results, including over two hundred and fifty successful 510(k) applications.”

In an effort to meet the growing demands of the medical device market, CSSi LifeSciences™’s team of medical device experts serve as a liaison for device manufacturers from inception to commercialization, leveraging deep subject matter expertise and regulatory experiences to effectively move new products to market with speed, accuracy, and the quality necessary to ensure safety, compliance, and health authority approval.

“Collectively, our medical device team has over 100 years of development and commercialization experience, coupled with global regulatory knowledge that goes beyond published guidance documents and initiatives,” said Sergi. “Our team possesses the necessary skills and resources to make our clients’ medical device efforts an end-user success.”

CSSi LifeSciences™ supports all phases of medical device development, from design engineering and testing to clinical studies and reimbursement. The company offers a broad suite of comprehensive and scalable services, including regulatory filings to US and foreign Notified Bodies; clinical study planning, monitoring, and reporting; FDA and EMA Agent for Foreign Registration; medical device testing and Design History Files; Quality Management Systems (21 CFR 820 and ISO 13485); health authority interactions; and, regulatory and scientific communication.

To learn more about CSSi LifeSciences™ Medical Device CRO, please visit www.cssilifesciences.com/cro.html, email info@cssilifesciences.com, or call (415) 317-4903.

About CSSi LifeSciences™:

CSSi LifeSciences™ provides fully integrated, specialized regulatory and clinical services to support the entire product lifecycle, from discovery to commercialization, for pharmaceutical and medical device companies. With global expertise, CSSi LifeSciences™ has been a key partner in the development of more than 500 drugs, biologics, medical devices, and in-vitro diagnostics. The company’s headquarters is located in Baltimore, MD, with additional offices in San Francisco, CA; London, UK; and Hyderabad, IND. For more information, visit www.cssilifesciences.com, email info@cssilifesciences.com, or call (415) 317-4903.

Offices and Locations
  • North America
  • 6958 Aviation Blvd
  • Suite H
  • Glen Burnie, MD 21061
  • P: 866.277.4888
  • E-mail: info@cssienroll.com
  • Europe
  • Kemp House,
  • City Road,
  • London, EC1V 2NX
  • P: 0203 693 3829
  • Asia
  • G-A, “Hyndava Techno Park”,
  • Plot No. 12,
  • Survey No. 64,
  • Hitec City, Phase 2,
  • Madhapur,
  • Hyderabad - 500081